Glembatumumab is a fully human IgG2 monoclonal antibody targeting the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. It is a naked antibody to Glembatumumab vedotin and can be used to study antibody-activated molecule couplings (Glembatumumab vedotin).
Purity:
97.31%
CAS Number:
[1020264-78-1]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted